Weight-loss medications like Ozempic and Zepbound have reshaped the way obesity is treated, but experts say they’re only part of the solution. In a recent commentary in the American Gastroenterological Association journal Gastroenterology, researchers revisited the influential POWER (Practice Guide on Obesity and Weight Management, Education, and Resources) framework, originally introduced in 2017. The updated framework reflects major developments in obesity care, from the arrival of highly effective weight loss medications to advances in endoscopic therapies, broader use of bariatric surgery, and the growing role of precision medicine.

GLP-1 Receptor Agonists: A Game-Changer in Obesity Treatment

According to the authors, GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy, and Rybelsus) and tirzepatide (Mounjaro and Zepbound), have significantly changed the obesity treatment landscape. These medications have been shown to be highly effective in promoting weight loss and improving glycemic control in patients with obesity. However, experts emphasize that these medications are only one piece of the puzzle when it comes to managing one of the most widespread chronic health conditions in the United States.

Obesity Treatment Is Expanding Beyond Medication

Obesity care is becoming increasingly comprehensive, combining medications with endoscopic procedures and surgical options when appropriate. The updated framework also incorporates the emerging concept of clinical obesity, which recognizes obesity as a chronic disease that affects multiple body systems. This approach highlights the limitations of relying solely on body mass index (BMI) to evaluate health risks.

New Evidence Supports Endoscopic Therapies

The commentary highlights growing evidence for endoscopic bariatric and metabolic therapies, including endoscopic sleeve gastroplasty, as effective treatment options for obesity. These minimally invasive procedures have been shown to be safe and effective in promoting significant weight loss and improving metabolic outcomes in patients with obesity.

Researchers also point to advances in genetics and precision medicine that could help physicians identify which treatments are most likely to benefit specific patients. As researchers learn more about the biological factors that influence obesity, treatment plans may become increasingly personalized.

Combining Therapies for Better Results

Another promising area involves combining therapies. Evidence suggests that pairing GLP-1 medications with endoscopic procedures or bariatric surgery could lead to greater weight loss and longer-lasting results than either approach alone. This approach highlights the importance of a multidisciplinary model of care, which brings together different therapeutic approaches to provide comprehensive treatment for patients with obesity.

Experts emphasize that obesity treatment is increasingly moving toward a multidisciplinary model that combines medications, procedures, and surgery. Rather than viewing these approaches as separate strategies, experts see them as complementary tools that can be tailored to individual patients. This approach recognizes that each patient is unique and requires a personalized treatment plan that addresses their specific needs and health status.

The Role of Gastroenterologists in Obesity Care

The paper also underscores the important role gastroenterologists and hepatologists play in treating obesity and its related health complications. These specialists frequently care for patients with obesity-associated conditions, including metabolic dysfunction-associated steatotic liver disease (MASLD), gastroesophageal reflux disease (GERD), gallbladder disease, and a range of gastrointestinal complications linked to obesity. Because of this close involvement, the authors argue that gastroenterologists and hepatologists are well positioned to help guide the future of obesity management as treatment options continue to evolve.

A New Era in Obesity Treatment

The updated framework reflects a new era in obesity treatment, one that recognizes the complexity of the disease and the need for a comprehensive approach. By combining medications, procedures, and surgery, experts aim to provide more effective and sustainable treatment for patients with obesity. This approach highlights the importance of a multidisciplinary model of care, which brings together different therapeutic approaches to provide comprehensive treatment for patients with obesity.

As researchers continue to learn more about the biological factors that influence obesity, treatment plans may become increasingly personalized. This approach recognizes that each patient is unique and requires a tailored treatment plan that addresses their specific needs and health status. By working together, experts aim to provide more effective and sustainable treatment for patients with obesity, ultimately improving health outcomes and quality of life.